Boston Scientific, US10117L1017

Boston Scientific stock heads into the open after a 0.9% gain

Published on 09/22/2026 at 03:49 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 21, 2026, Boston Scientific stock finished at USD 43.72 on the New York Stock Exchange, up 0.9% for the day. The shares traded between USD 42.72 and USD 43.81, while the S&P 500 also advanced, helping the stock into today’s session.

Sterile Fertigungslinie für Herzkathetersysteme in einem Medizintechnik-Reinraum in Marlborough MA
Boston Scientific Corp. betreibt sterile Reinraumfertigung für Herzkathetersysteme am Standort Marlborough MA, ISIN US10117L1017, Illustration mit AI erstellt.

Boston Scientific stock closed at USD 43.72 on the New York Stock Exchange on September 21, 2026, gaining 0.88% compared with the prior session. The move came as the shares traded within a daily range between USD 42.72 at the low and USD 43.81 at the high, with reported volume of about 24,423,389 shares for the day.

September 21, 2026 in numbers

Boston Scientific Corp. (ISIN US10117L1017, NYSE: BSX) finished the last completed session on September 21, 2026 at USD 43.72, up from a prior close of USD 43.34, which translates into an increase of roughly 0.88% for the day per New York closing data. Price history data for Boston Scientific show that on September 21, 2026 the shares traded between an intraday high of USD 43.81 and an intraday low of USD 42.72, with total volume around 24,423,389 shares in the regular session.

Over the same session on September 21, 2026, the broader United States equity market also advanced, with the Dow Jones Industrial Average closing higher by 366.19 points, or 0.71%, to 52,048.83 according to Wikitree. This backdrop meant Boston Scientific kept pace with a generally positive trading day, and at a last price of USD 43.72 the shares stood modestly above the lower end of their recent 52-week range between USD 42.20 and USD 55.65 in USD terms as indicated by New York price data.

Outlook for today

For today, September 22, 2026, investors follow Boston Scientific against a constructive broader market tone after the prior session’s gains, with United States equity futures described as little changed following the strong performance of the S&P 500 in the previous trading day by CNBC. While no specific company events such as earnings or an annual meeting for Boston Scientific are scheduled for today in the available calendars, the shares remain sensitive to moves in major United States health care and medical device peers and to macroeconomic data releases that can influence risk appetite across the S&P 500. In this context, the stock enters today’s New York session from a position slightly above its recent lows, with the prior close at USD 43.72 giving traders a fresh reference point for intraday decisions.

Disclaimer...

en | US10117L1017 | BOSTON SCIENTIFIC | boerse | 70149085 | bgmi